HomeInsightsStock Comparison

Lupin Ltd vs Zydus Lifesciences Ltd Stock Comparison

Lupin Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Sep 28, 2025

Key Highlights

  • The Latest Trading Price of Lupin Ltd is ₹ 1920 as of 26 Sep 15:30.
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 28.2 on March 2025 . This represents a CAGR of -5.84% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 19.7 on March 2025 . This represents a CAGR of -2.76% over 6 years.
  • The Market Cap of Lupin Ltd changed from ₹ 26713 crore on March 2020 to ₹ 92522 crore on March 2025 . This represents a CAGR of 23.00% over 6 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 89122 crore on March 2025 . This represents a CAGR of 21.76% over 6 years.
  • The revenue of Lupin Ltd for the Jun '25 is ₹ 6347 crore as compare to the Mar '25 revenue of ₹ 5724 crore. This represent the growth of 10.89% The revenue of Zydus Lifesciences Ltd for the Jun '25 is ₹ 6728 crore as compare to the Mar '25 revenue of ₹ 6608 crore. This represent the growth of 1.82%.
  • The ebitda of Lupin Ltd for the Jun '25 is ₹ 1806 crore as compare to the Mar '25 ebitda of ₹ 1378 crore. This represent the growth of 31.07% The ebitda of Zydus Lifesciences Ltd for the Jun '25 is ₹ 2243 crore as compare to the Mar '25 ebitda of ₹ 1986 crore. This represent the growth of 12.93%.
  • The net profit of Lupin Ltd changed from ₹ 453.33 crore to ₹ 1221 crore over 9 quarters. This represents a CAGR of 55.35% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1486 crore over 9 quarters. This represents a CAGR of 13.77% .
  • The Dividend Payout of Lupin Ltd changed from 37.36 % on March 2020 to 13.79 % on March 2025 . This represents a CAGR of -15.30% over 6 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 19.16 % on March 2025 . This represents a CAGR of -4.57% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Lupin Ltd News Hub

News

Lupin gains after USFDA clears HIV drug for tentative launch

The drug is the generic version of Biktarvy Tablets (50 mg/200 mg/25 mg), marketed by Gile...

Read more

25 Sep 2025 09:30

News

Lupin receives USFDA tentative approval for Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets

Lupin has received tentative approval from the United States Food and Drug Administration ...

Read more

24 Sep 2025 19:39

News

Lupin's Pune Biotech facility undergoes USFDA pre-approval inspection

The inspection concluded with 4 observations, the company said in a regulatory filing. The...

Read more

22 Sep 2025 09:31

News

Lupin's Pune Biotech unit concludes USFDA inspection

Lupin announced that USFDA has conducted a product-specific Pre-Approval Inspection at the...

Read more

20 Sep 2025 15:09

News

Lupin slides after receiving six observations from USFDA for Nagpur facility

According to a regulatory filing, the inspection was carried out from 8 September to 16 Se...

Read more

17 Sep 2025 09:17

News

Lupin receives USFDA approval for Lenalidomide Capsules

Lupin today announced that it has received approval from the United States Food and Drug A...

Read more

17 Sep 2025 18:16

Zydus Lifesciences Ltd News Hub

News

Zydus Life receives EIR from USFDA for Ahmedabad facility

The inspection was conducted from 9th to 18th June 2025. The EIR has classified the facili...

Read more

22 Sep 2025 10:09

News

ZyVet' Animal Health launches first FDA-approved generic of phenylpropanolamine hydrochloride tablets

ZyVet' Animal Health, a leader in affordable generic pharmaceuticals for animals, a wholly...

Read more

15 Sep 2025 19:09

News

ZyVet' Animal Health launches first veterinary approved generic of Furosemide Tablets

ZyVet' Animal Health, a leader in affordable generic pharmaceuticals for animals and a who...

Read more

15 Sep 2025 19:11

News

Zydus Lifesciences gets 4 USFDA observations after inspection at Jarod Injectable facility

The inspection was conducted over a 12-day period, from 25th August to 5th September 2025,...

Read more

06 Sep 2025 09:55

News

Zydus appoints Nitin D. Parekh as President (Special Projects)

The board of directors of Zydus Lifesciences have approved the appointment of Nitin D. Par...

Read more

05 Sep 2025 09:49

News

Zydus Life gains as arm inks supply agreement with Synthon BV for Ozanimod capsules

Synthon has filed an abbreviated new drug application (ANDA) with the US Food and Drug Adm...

Read more

05 Sep 2025 11:21

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lupin Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Lupin Ltd or Zydus Lifesciences Ltd?

Market cap of Lupin Ltd is 87,731 Cr while Market cap of Zydus Lifesciences Ltd is 98,213 Cr

What are the key factors driving the stock performance of Lupin Ltd and Zydus Lifesciences Ltd?

The stock performance of Lupin Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Zydus Lifesciences Ltd?

As of September 28, 2025, the Lupin Ltd stock price is INR ₹1920.75. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹976.05.

How do dividend payouts of Lupin Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Lupin Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions